Cargando…
Intravitreal Dexamethasone Implant (Ozurdex) in Coats’ Disease
We injected an intravitreal dexamethasone implant in two eyes of 2 pediatric patients with Coats’ disease in addition to other treatment modalities, such as intravitreal ranibizumab injection and indirect laser photocoagulation. In both eyes, intraocular pressure moderately rose in a temporary fashi...
Autores principales: | Saatci, Ali Osman, Doruk, Hasan Can, Yaman, Aylin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806670/ https://www.ncbi.nlm.nih.gov/pubmed/24163679 http://dx.doi.org/10.1159/000355363 |
Ejemplares similares
-
Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema
por: Saatci, Ali Osman, et al.
Publicado: (2013) -
Splitting of a Dexamethasone Implant (Ozurdex) following the Injection
por: Donmez, Oya, et al.
Publicado: (2013) -
Dexamethasone Implant (Ozurdex) in a Case with Unilateral Simultaneous Central Retinal Vein and Branch Retinal Artery Occlusion
por: Ozturk, Taylan, et al.
Publicado: (2015) -
Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation
por: Martínez-Castillo, Sebastián, et al.
Publicado: (2012) -
Use of an Intravitreal Dexamethasone Implant (Ozurdex) in a Case with Accidental Foveal Photocoagulation by Alexandrite Laser
por: Bulut, Muhammed Nurullah, et al.
Publicado: (2016)